Covered recipient · General Payments record
ELIAS COHENZADEH
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2021
$506.52
- Reported across 23 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2021 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $260.31 | 9 |
By paying entity
PY2021 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GlaxoSmithKline, LLC. | $118.58 | 1 |
| Merck Sharp & Dohme Corporation | $36.30 | 2 |
| Lilly USA, LLC | $31.71 | 2 |
| Gilead Sciences, Inc. | $26.72 | 1 |
| Ultragenyx Pharmaceutical Inc. | $18.35 | 1 |
| Amarin Pharma Inc. | $14.99 | 1 |
| SANOFI PASTEUR INC. | $13.66 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2021 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amarin Pharma Inc. | $14.99 | 04/27/2021 | Food and Beverage | Undisputed | 01/23/2026 | 815414919 | CMS |
| Gilead Sciences, Inc. | $26.72 | 04/14/2021 | Food and Beverage | Undisputed | 01/23/2026 | 848178939 | CMS |
| GlaxoSmithKline, LLC. | $118.58 | 07/27/2021 | Food and Beverage | Undisputed | 01/23/2026 | 801564767 | CMS |
| Lilly USA, LLC | $17.32 | 02/04/2021 | Food and Beverage | Undisputed | 01/23/2026 | 819106863 | CMS |
| Lilly USA, LLC | $14.39 | 10/18/2021 | Food and Beverage | Undisputed | 01/23/2026 | 819172943 | CMS |
| Merck Sharp & Dohme Corporation | $18.41 | 05/05/2021 | Food and Beverage | Undisputed | 01/23/2026 | 848367209 | CMS |
| Merck Sharp & Dohme Corporation | $17.89 | 08/26/2021 | Food and Beverage | Undisputed | 01/23/2026 | 848626439 | CMS |
| SANOFI PASTEUR INC. | $13.66 | 06/16/2021 | Food and Beverage | Undisputed | 01/23/2026 | 838105569 | CMS |
| Ultragenyx Pharmaceutical Inc. | $18.35 | 09/21/2021 | Food and Beverage | Undisputed | 01/23/2026 | 848961893 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021
- Generated from
- OP_DTL_GNRL_PGYR2021_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.